Mercurio Lab News
Our assistant professor Hira Goel also published in collaboration with aTyr Pharma “Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer”. Congrats Hira!!
Our post-doc Mandy Wang led the paper “Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer”. Her work was featured on the cover of this issue! Congrats Mandy!!
Jessica has chosen the Mercurio Lab for her final rotation.
Jessica is a first-year graduate student in the Basic & Biomedical Sciences Ph.D. Program at UMass Chan Medical School.
We are happy to be a part of your journey! Welcome!
The 2022 Cell Bio Conference in Washington DC hosted by the American Society for Cell Biology (ASCB) and the European Molecular Biology Organization (EMBO) featured advances in multiple areas of cell biology.
Our Post-doc Mandy had to opportunity to present her poster on “PD-L1 promotes rear retraction during persistent cell migration by altering intergrin beta-4 dynamics.”
Mandy attends AACR Special Conference on Tumor Immunology and Immunotherapy to further share her work on “Therapeutic Blocking of VEGF Binding to Neuropilin-2 Diminishes PD-L1 Expression to Activate Anti-Tumor Immunity in Prostate Cancer.”
This week our postdoc Mandy Wang attended the Cancer Immunotherapy Conference hosted by the Cancer Research Institute, the European Network for Cancer Immunotherapy, and the American Association for Cancer Research. This conference focused on “Translating Science into Survival.”
Mandy was able to present a poster highlighting her work on “Therapeutic blocking of VEGF binding to neuropilin-2 inhibits PD-L1 to activate anti-tumor immunity in prostate cancer.”
You can find her abstract and all of the other abstracts from the conference here.
